Multivariate Analyses of the Clinical and Molecular Parameters Associated with Efficacy and Safety in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Treated with Ponatinib in the PACE Trial
Year: 2012
Type: article
Source: Blood
Authors: Michael J. Mauro, Jorge E. Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane Apperley, H. Jean Khoury, Moshe Talpaz, John F. DiPersio, Daniel J DeAngelo, Elisabetta Abruzzese, Delphine Rea, Michele Baccarani, Martin C Muller, Carlo Gambacorti-Passerini, Stephane Wong, David J. Dorer, Ronald Keith Knickerbocker, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G Haluska, Francois Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy Hughes, John M Goldman, Neil Shah, Hagop M. Kantarjian, The PACE Study Group
Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, The University of Texas MD Anderson Cancer Center, The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, Moffitt Cancer Center, Charité - Universitätsmedizin Berlin, University of California, Los Angeles, National University of Singapore, Singapore General Hospital, Duke-NUS Medical School, Hôpital Lyon Sud, Hammersmith Hospital, Imperial College London, Winship Cancer Institute, University of Michigan, Washington University in St. Louis, Dana-Farber Cancer Institute, University of Rome Tor Vergata, St. Eugenio Hospital, Hôpital Saint-Louis, Recherche clinique appliquée à l'hématologie, University of Bologna, University Medical Centre Mannheim, Medizinische Fakultät Mannheim, Azienda Ospedaliera San Gerardo, University of Milano-Bicocca, ARIAD Pharmaceuticals (United States), Centre Hospitalier Universitaire de Poitiers, University of Utah, Huntsman Cancer Institute, Jena University Hospital, South Australia Pathology, Royal Adelaide Hospital, University of California, San Francisco
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2516535433